Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
Oncotargets and Therapy|August 30, 2012
Safety profiles of current antiangiogenic therapies for metastatic colorectal cancerJyotsna FuloriaWorld Journal of Gastrointestinal Oncology|January 23, 2016
Novel therapeutic agents in the treatment of metastatic colorectal cancerSachin Gopalkrishna Pai, Jyotsna FuloriaOchsner Journal|July 24, 2012
The role of chemotherapy in colon cancerAna Maria Gonzalez-Angulo, Jyotsna FuloriaInternational Journal of Environmental Research and Public Health|March 25, 2022
Landscape of Molecular Crosstalk Perturbation between Lung Cancer and COVID-19Aditi Kuchi, Jiande Wu, Jyotsna Fuloria, et al.Ochsner Journal|July 2, 2015
Rituximab-Induced Acute ST Elevation Myocardial InfarctionAmit N Keswani, Cody Williams, Jyotsna Fuloria, et al.Advances in Therapy|October 27, 2020
Design and Rationale of a Randomized, Double-Blind, Placebo-Controlled, Phase 2/3 Study Evaluating Dociparstat in Acute Lung Injury Associated with Severe COVID-19Joseph A Lasky, Jyotsna Fuloria, Marion E Morrison, et al.Breast Cancer Research : BCR|October 9, 2009
Phase I dose escalation pharmacokinetic assessment of intravenous humanized anti-MUC1 antibody AS1402 in patients with advanced breast cancerMark D Pegram, Virginia F Borges, Nuhad Ibrahim, et al.Clinical Pharmacokinetics|April 24, 2009
Effect of the cytochrome P450 2C19 inhibitor omeprazole on the pharmacokinetics and safety profile of bortezomib in patients with advanced solid tumours, non-Hodgkin's lymphoma or multiple myelomaDavid I Quinn, John Nemunaitis, Jyotsna Fuloria, et al.Translational Cancer Research|February 4, 2022
Knowledge and attitudes towards low dose computed tomography lung cancer screening and smoking among African Americans-a mixed method studyTung-Sung Tseng, Tyra Gross, Michael D Celestin, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 27, 2009
Osteoporosis prevention in prostate cancer patients receiving androgen ablation therapy: placebo-controlled double-blind study of estradiol and risedronate: N01C8Ann E Kearns, Donald W Northfelt, Amylou C Dueck, et al.Pageof 2